These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 5973523)
21. [On the position of butyrophenone derivative Triperidol in psychiatric treatment]. Lange E; Scholz V Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(6):202-7. PubMed ID: 5731875 [No Abstract] [Full Text] [Related]
22. De novo onset of Parkinson's disease after antidepressant treatment with citalopram. Stadtland C; Erfurth A; Arolt V Pharmacopsychiatry; 2000 Sep; 33(5):194-5. PubMed ID: 11071022 [No Abstract] [Full Text] [Related]
23. [Considerations on 30 patients treated with sulpiride]. Cottraux J; Pellet J Sem Hop; 1970 Jun; 46(29):Suppl:117-23. PubMed ID: 4316822 [No Abstract] [Full Text] [Related]
24. [Sulpiride, an unusual neuroleptic anti-autism and thymoanaleptic drug]. Collard J Sem Hop; 1969 Nov; 45(48):3028-33. PubMed ID: 4312500 [No Abstract] [Full Text] [Related]
25. [Clinical trial of delayed-action Akinophyl (Akineton)]. Delteil P; Decreton C Ann Med Psychol (Paris); 1972 May; 1(5):696-709. PubMed ID: 5081113 [No Abstract] [Full Text] [Related]
26. Aletamine in hospitalized schizophrenic patients--negative report. Nachand DW; Kurland AA; Hanlon TE J Clin Pharmacol J New Drugs; 1967; 7(2):116-7. PubMed ID: 5339906 [No Abstract] [Full Text] [Related]
27. [Initial results of clinical trial of a new long-acting neuroleptic agent: Fluspirelene]. Ciccarelli G; Nosè F Minerva Med; 1971 Dec; 62(98):4922-7. PubMed ID: 5141918 [No Abstract] [Full Text] [Related]
28. Drug-induced parkinsonism: relationship to age at onset of schizophrenia. Sandyk R; Kay SR Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777 [TBL] [Abstract][Full Text] [Related]
29. [Frenolon in psychiatry. A few thoughts on a new neuroleptic from the group of phenothiazines]. Pagàn J Lyon Med; 1967 Jun; 217(26):951-4. PubMed ID: 5611642 [No Abstract] [Full Text] [Related]
30. Schizophrenic and paranoid disorders in the aged. Varner RV; Gaitz CM Psychiatr Clin North Am; 1982 Apr; 5(1):107-18. PubMed ID: 6124954 [No Abstract] [Full Text] [Related]
31. Controlled study of BL-KR140 on chronic anergic schizophrenic patients stabilized with a neuroleptic compound. Dim BH; Kurland AA Curr Ther Res Clin Exp; 1968 Jun; 10(6):288-91. PubMed ID: 4969835 [No Abstract] [Full Text] [Related]
32. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome]. Kamianov IM; Kupisk AG; Katsen IZ Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581 [No Abstract] [Full Text] [Related]
33. [Use of haloperidol in residual schizophrenia and in the paranoid states]. Jeri FR Rev Neuropsiquiatr; 1970 Jun; 33(2):114-22. PubMed ID: 5509272 [No Abstract] [Full Text] [Related]
34. [Attempt of evaluation of sordinol in treatment of chronic paranoid schizophrenia]. Grabowski K; Sujecka-Szymkiewicz H Neurol Neurochir Psychiatr Pol; 1966 Oct; 16(10):1179-83. PubMed ID: 5993466 [No Abstract] [Full Text] [Related]
35. [Antidepressant treatment of schizophrenic patients]. Caroli F; Baldacci-Epinette C; Ribeyre P Encephale; 1993 Jul; 19 Spec No 2():393-6. PubMed ID: 7904237 [TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of a new neuroleptic "thiothixene" (p-4657 b). Gómez-Martínez I Psychiatr Neurol (Basel); 1967; 153(4):219-25. PubMed ID: 5340209 [No Abstract] [Full Text] [Related]
37. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses. Salvesen C; Vaksdal K Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740 [No Abstract] [Full Text] [Related]